# Cyclophosphamide

## Endoxan Asta inj 200mg

#### 一般可用

| 藥品代碼       | IEND                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:---------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Treatment of acute lymphoblastic leukemia (ALL)， acute myelocytic leukemia (AML)， breast cancer， chronic lymphocytic leukemia (CLL)， chronic myeloid leukemia (CML)， Hodgkin lymphoma， mycosis fungoides， multiple myeloma， neuroblastoma， non-Hodgkin lymphomas (including Burkitt lymphoma)， ovarian adenocarcinoma， retinoblastoma， and nephrotic syndrome.                                                                                                                                                                                             |
| 用法用量       | The dosage must be adapted to each patient individually.Unless otherwise prescribed the following dosages are recommended: - for continuous treatment in adults and children: 3-6 mg/kg body weight daily (= 120-240 mg/m2 body surface) - for intermittent treatment: 10-15 mg/kg body weight (= 400-600 mg/m2 body surface) at intervals of 2-5 days - for high-dose intermittent treatment， e.g. 20-40 mg/kg body weight (= 800-1600 mg/m2 body surface) and higher doses (e.g. for conditioning prior to bone-marrow transplantation) at intervals of 21-28 days. |
| 肝功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 腎功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 禁忌           | Hypersensitivity to cyclophosphamide or its metabolites， urinary outflow obstructions， severe myelosuppression， severe renal or hepatic impairment， active infection (especially varicella zoster)， severe immunosuppression.                                                                                                                                                                                                                                                                                                                                     |
| 副作用         | GI upsets; alopecia; reticulo-endothelial system depression; hematuria; reversible amenorrhea & azoospermia; myocardial damage with very high doses; pigmentation， macrocytosis， water retention; induction of hyperglycemia or hypoglycemia; risk of secondary malignancies.                                                                                                                                                                                                                                                                                        |
| 孕期用藥建議   | Contraindicated – 1st trimester                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 哺乳期用藥建議 | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

## Endoxan 50mg

#### 一般可用

| 藥品代碼       | OEND                                                                                                                                                                                                                                                                                                                                                                       |
|:---------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Treatment of acute lymphoblastic leukemia (ALL)， acute myelocytic leukemia (AML)， breast cancer， chronic lymphocytic leukemia (CLL)， chronic myeloid leukemia (CML)， Hodgkin lymphoma， mycosis fungoides， multiple myeloma， neuroblastoma， non-Hodgkin lymphomas (including Burkitt lymphoma)， ovarian adenocarcinoma， retinoblastoma， and nephrotic syndrome. |
| 用法用量       | For continuous therapy 1-4 tablets (50-200 mg) daily; if necessary， more tablets may be taken. The dose recommendations given mainly apply to the treatment with cyclophosphamide as a monotherapy. In combination with other cytostatics of similar toxicity， a dose reduction or extension of the therapy-free intervals may be necessary.                             |
| 肝功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                 |
| 腎功能異常     | 需調整劑量                                                                                                                                                                                                                                                                                                                                                                 |
| 禁忌           | Hypersensitivity to cyclophosphamide or its metabolites， urinary outflow obstructions， severe myelosuppression， severe renal or hepatic impairment， active infection (especially varicella zoster)， severe immunosuppression.                                                                                                                                         |
| 副作用         | Nausea， vomiting; bone marrow depression， leukopenia; alopecia; mucosal ulceration; pigmentation; interstitial pulmonary fibrosis; fluid retention                                                                                                                                                                                                                       |
| 孕期用藥建議   | Contraindicated – 1st trimester                                                                                                                                                                                                                                                                                                                                            |
| 哺乳期用藥建議 | Contraindicated 哺乳期使用禁忌                                                                                                                                                                                                                                                                                                                                             |

